These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1713662)

  • 1. Defective induction of Jun and Fos-related proteins in phorbol ester-resistant EL4 mouse thymoma cells.
    Jensen DE; Frankis RC; Sando JJ
    Oncogene; 1991 Jul; 6(7):1219-25. PubMed ID: 1713662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective up-regulation of protein kinase C eta in phorbol ester-sensitive versus -resistant EL4 mouse thymoma cells.
    Resnick MS; Luo X; Vinton EG; Sando JJ
    Cancer Res; 1997 Jun; 57(11):2209-15. PubMed ID: 9187123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phorbol ester receptors in T-cell growth factor-producing and -nonproducing EL4 mouse thymoma cells.
    Sando JJ; Hilfiker ML; Piacentini MJ; Laufer TM
    Cancer Res; 1982 May; 42(5):1676-80. PubMed ID: 6978177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R; Beck WT
    Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain.
    Sonnenberg JL; Mitchelmore C; Macgregor-Leon PF; Hempstead J; Morgan JI; Curran T
    J Neurosci Res; 1989 Sep; 24(1):72-80. PubMed ID: 2553994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription.
    Yang-Yen HF; Chiu R; Karin M
    New Biol; 1990 Apr; 2(4):351-61. PubMed ID: 1963081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone and serum on the expression of the proto-oncogenes c-jun and c-fos in insulin producing cells.
    Petersen ED; Billestrup N; Nielsen JH
    Biomed Biochim Acta; 1990; 49(12):1171-5. PubMed ID: 2129102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
    Touray M; Ryan F; Jaggi R; Martin F
    Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells.
    Mondino A; Whaley CD; DeSilva DR; Li W; Jenkins MK; Mueller DL
    J Immunol; 1996 Sep; 157(5):2048-57. PubMed ID: 8757326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
    Goode NT; Moore JP; Hart IR
    Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
    Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
    Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
    Kumagai N; Benedict SH; Mills GB; Gelfand EW
    J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hepatic proliferation-associated transcription factors by lipopolysaccharide.
    Beauchamp RD; Papaconstantinou J; Henderson AM; Sheng HM; Townsend CM; Thompson JC
    Surgery; 1994 Aug; 116(2):367-76; discussion 376-7. PubMed ID: 8048002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
    Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM
    J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.